2018 - Member of Academia Europaea
2009 - Fellow of the Royal Society, United Kingdom
Her primary scientific interests are in Immunology, Virology, Vaccination, Virus and Viral load. Angela R. McLean has researched Immunology in several fields, including Cytotoxic T cell, Acquired immunodeficiency syndrome and In vivo. The Virology study which covers Disease that intersects with Demography.
Her research in Vaccination intersects with topics in Mathematical modelling of infectious disease, Predictive factor, Vaccination coverage and Environmental health. Her work in Virus tackles topics such as Immune system which are related to areas like Viral evolution, Retrovirus and Epitope. Her study looks at the intersection of Viral load and topics like Drug resistance with Viremia, Virus latency, Post-exposure prophylaxis, Simian immunodeficiency virus and Doubling time.
Her main research concerns Immunology, Virology, Virus, Cytotoxic T cell and Viral load. Her Immunology research incorporates elements of Acquired immunodeficiency syndrome and Disease. Her Virology research is multidisciplinary, incorporating perspectives in Epitope, CD8 and Drug resistance.
Her specific area of interest is Cytotoxic T cell, where Angela R. McLean studies CTL*. Her work investigates the relationship between Immune system and topics such as Antigen that intersect with problems in In vitro, T cell and In vivo. Her Vaccination study incorporates themes from Epidemiology and Environmental health.
The scientist’s investigation covers issues in Virology, Immunology, Genetics, CTL* and Viral load. She conducts interdisciplinary study in the fields of Virology and Incubation period through her research. Her Immunology research incorporates themes from Internal medicine and Hepatology.
Her work carried out in the field of CTL* brings together such families of science as Epitope and Human leukocyte antigen. Her Viral load study combines topics from a wide range of disciplines, such as Acute infection, Simian, Transmission, Viral replication and Chronic infection. Her Virus research is multidisciplinary, incorporating elements of T cell, Immune system and Drug resistance.
Angela R. McLean spends much of her time researching Virology, Immunology, Ecology, Neonicotinoid and Natural science. Her studies in Virology integrate themes in fields like Physiology and Dose–response relationship. Her study in Immunology is interdisciplinary in nature, drawing from both Transmission and Viral evolution.
Her studies deal with areas such as Measles, Poliomyelitis, Disease Elimination and Malaria as well as Transmission. Her work in the fields of Ecology, such as Insect, intersects with other areas such as Environmental ethics, European union, Policy relevance and Pollinator. Angela R. McLean combines subjects such as HLA-B Antigens, Seroprevalence, Immune system and Drug resistance with her study of Viral load.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Theoretical Ecology: Principles and Applications
Robert May;Angela McLean.
Lifespan of human lymphocyte subsets defined by CD45 isoforms.
Colin A. Michie;Angela McLean;Christopher Alcock;Peter C. L. Beverley.
Response of naïve and memory CD8+ T cells to antigen stimulation in vivo.
Henrique Veiga-Fernandes;Ulrich Walter;Christine Bourgeois;Angela McLean.
Nature Immunology (2000)
Antigenic diversity thresholds and the development of AIDS
Martin A. Nowak;Roy M. Anderson;Angela R. McLean;Tom F. W. Wolfs.
The intrinsic transmission dynamics of tuberculosis epidemics.
Sally M. Blower;Angela R. Mclean;Travis C. Porco;Peter M. Small.
Nature Medicine (1995)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo;Helen R. Fryer;Trevor Bedford;Eun Young Kim.
A restatement of the natural science evidence base concerning neonicotinoid insecticides and insect pollinators
Proceedings of The Royal Society B: Biological Sciences (2014)
Viral Dynamics of Acute HIV-1 Infection
Susan J. Little;Angela R. McLean;Celsa A. Spina;Celsa A. Spina;Douglas D. Richman;Douglas D. Richman.
Journal of Experimental Medicine (1999)
In vivo estimates of division and death rates of human T lymphocytes.
Angela R. McLean;Colin A. Michie.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
SM Blower;AR McLean.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: